Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2
about
Pathogen recognition and activation of the innate immune response in zebrafishZ proteins of New World arenaviruses bind RIG-I and interfere with type I interferon inductionDEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potentialCaspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I.Immune signaling by RIG-I-like receptorsA novel function of human Pumilio proteins in cytoplasmic sensing of viral infectionZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responsesRegulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infectionMDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signalingDDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signalingSolution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptorsA shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNAStructure and function of LGP2, a DEX(D/H) helicase that regulates the innate immunity responseReplication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon inductionFunction and regulation of retinoic acid-inducible gene-IInnate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNAPathogen recognition and inflammatory signaling in innate immune defensesLGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responsesLength-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6Immune Activation in the Liver by Nucleic AcidsUbiquitin in the activation and attenuation of innate antiviral immunityImmune and non-immune responses to hepatitis C virus infectionDED or alive: assembly and regulation of the death effector domain complexesRegulation of hepatic innate immunity by hepatitis C virusInterferon induction by RNA viruses and antagonism by viral pathogensInnate receptors and cellular defense against pulmonary infectionsMDA5 and LGP2: accomplices and antagonists of antiviral signal transductionHepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human HepatocytesDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate ImmunityEstablishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1Toll-like receptors regulation of viral infection and disease☆Negative regulation of cytoplasmic RNA-mediated antiviral signalingHepatitis C and Innate Immunity: Recent AdvancesAgonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity ReceptorNucleotide Sequences and Modifications That Determine RIG-I/RNA Binding and Signaling ActivitiesGene expression and hepatitis C virus infection
P2860
Q21296719-60921AED-B18F-444C-84EF-9225C164678DQ22001518-11C9A58F-1714-4D5B-BCB0-C0456BAB8E1FQ24298235-9A2E52EA-20D8-4079-9EBB-34B4D0E78188Q24298724-954503E7-3323-44F2-8BE6-68CCBFAA7B82Q24304438-48D10B16-8F37-4834-9CA6-99ED4DBC030DQ24306232-98524B5F-B75A-48DF-9234-75578DD26656Q24307928-CFD58996-5FDA-4CE0-BABA-D071B98EA778Q24310270-2DA63FA9-8204-4058-BABB-B6AA315ECE74Q24315899-02EBFD85-3CD3-48EC-A6EC-726B13F13037Q24316163-4E9182A0-FFAA-4637-BB16-474679F9AD38Q24317028-798F80FC-CB9D-45E6-AFD3-B05EF4562C5DQ24317636-80640C9B-DE8B-47C5-8506-2FCF0C2D5227Q24320094-F3568570-9753-4C0E-A81A-7F76698F7B2CQ24320147-B24B02C5-9F86-4A52-A989-EC08F4B57C2AQ24321366-FA9B8889-9927-41E7-B57D-214509163A88Q24611792-6AF2AC39-73E2-478B-85EE-58776CD776CCQ24617419-FE53545C-AE8D-40FA-8FC6-9401F6570AF6Q24632537-F17FC11D-0DE2-4726-A468-2532C89A184EQ24634416-99024C2C-E9E2-413A-9E4B-49BF7FF74E7CQ24643034-38186945-54FE-4181-ADD3-0D80439E2471Q24645870-69B68AA8-F924-4215-ABF8-AAE79CCA118AQ24648192-41072B64-DEA6-4A87-8BDA-C7AE80B73391Q26700093-2AE6B8C4-B0CA-40F8-BA38-53130022A2A8Q26746467-A976E93A-6C4B-4352-8565-066AB9A3EA84Q26771789-D41E640D-E1AE-43DA-81A1-6E64B3A8A528Q26782040-3330E8CD-3562-4A8F-A4BA-FBDA9B65EC20Q26796544-C126D27D-F04F-40B7-B08F-F3262E74811BQ26824743-2F68147F-30EE-4D96-AAA7-9AE59D5983D8Q26860007-D898C8C3-222D-40EA-B1F7-2A4C92D25D2FQ26996036-43283536-16A1-4D47-A2E7-1FAD73FEAA6EQ27010611-FD581A7B-ADC7-4029-A8C2-FFE7CF9CB918Q27485023-2AFFCAE3-D7E1-4D09-9FDF-504CB2461EAFQ27485306-9BC021AE-16FA-4F9E-8D9E-5985E513F3C7Q27485316-534BECEE-0660-432A-A6BC-FD1A49F7D66DQ27486231-210F51AB-4FE4-423D-9FF8-DDC4F7CF64BEQ27487296-ABC5E384-5CCC-48F7-BB50-DBB35303F786Q27487394-AD7E11B9-DE82-4737-9584-A354E361BB5CQ27487543-3EE16C6E-D82D-4A67-9292-52D16F6FCFE1Q27488308-5BE2D7B7-D780-4892-863A-6284BAE9C514Q27488345-9B8BE2C5-3B80-4894-B7C5-C89B02B589FF
P2860
Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@ast
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en-gb
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@nl
type
label
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@ast
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en-gb
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@nl
prefLabel
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@ast
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en-gb
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@nl
P2093
P2860
P50
P3181
P356
P1476
Regulation of innate antiviral ...... essor domain in RIG-I and LGP2
@en
P2093
Cynthia L Johnson
Reiko Hirai
Sangita C Sinha
Takashi Fujita
Takeshi Saito
Yueh-Ming Loo
P2860
P3181
P356
10.1073/PNAS.0606699104
P407
P577
2007-01-09T00:00:00Z